Bolt Biotherapeutics
BOLT
BOLT
65 hedge funds and large institutions have $84.8M invested in Bolt Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
43% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 23
49% less capital invested
Capital invested by funds: $165M → $84.8M (-$79.9M)
Holders
65
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.49M | |
| 2 | +$1.1M | |
| 3 | +$854K | |
| 4 |
HCM
Hawkeye Capital Management
Miami Beach,
Florida
|
+$677K |
| 5 |
Renaissance Technologies
New York
|
+$551K |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$3.87M | |
| 3 | -$1.98M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.62M |
| 5 |
Goldman Sachs
New York
|
-$1.18M |